Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial

This publication has 21 references indexed in Scilit:

• A Comparison of Aspirin plus Tirofiban with Aspirin plus Heparin for Unstable Angina
  New England Journal of Medicine, 1998
• Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial Infarction
  New England Journal of Medicine, 1998
• A Comparison of Recombinant Hirudin with a Low-Molecular-Weight Heparin to Prevent Thromboembolic Complications after Total Hip Replacement
  New England Journal of Medicine, 1997
• A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease
  New England Journal of Medicine, 1997
• Aspirin, Heparin, and Fibrinolytic Therapy in Suspected Acute Myocardial Infarction
  New England Journal of Medicine, 1997
• A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
  The Lancet, 1996
• A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary Syndromes
  New England Journal of Medicine, 1996
• An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial Infarction
  New England Journal of Medicine, 1993
• Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.
  Journal of Clinical Investigation, 1990
• Aspirin, Heparin, or Both to Treat Acute Unstable Angina
  New England Journal of Medicine, 1988